StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · SXTC·Healthcare

China SXT Pharmaceuticals, Inc. Stock Analysis & AI Score

China SXT Pharmaceuticals, Inc. (SXTC) has an ST Score of 43.8 (C), driven by its Financial Strength (A+) and held back by its Momentum (F). SXTC last traded at $2.55.

Market Closed
$2.55
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
44
ST Score
43.8/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

SXTC
43.8out of 100
Grade C

China SXT Pharmaceuticals, Inc. (SXTC) has an ST Score of 43.8 (C), driven by its Financial Strength (A+) and held back by its Momentum (F). SXTC last traded at $2.55.

Strongest
Financial StrengthA+
Weakest
MomentumF
All factor grades
  • Financial StrengthA+
  • ValuationB+
  • GrowthC+
  • ProfitabilityD-
  • MomentumF
  • Piotroski4/9
Score methodology
Press Releases

Contact

SXTC stock: frequently asked questions

What is SXTC's ST Score?

China SXT Pharmaceuticals, Inc. (SXTC) has an ST Score of 43.8 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is SXTC a buy, hold, or sell?

Our ST Score grades it C (43.8/100). The ST Score is a data-driven signal, not a recommendation.

What are SXTC's factor grades?

Valuation B+, Profitability D-, Financial Strength A+, Momentum F, Growth C+.

What is SXTC's valuation grade?

China SXT Pharmaceuticals, Inc. (SXTC) earns a valuation grade of B+, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is SXTC's growth grade?

China SXT Pharmaceuticals, Inc. (SXTC) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is SXTC's profitability grade?

China SXT Pharmaceuticals, Inc. (SXTC) earns a profitability grade of D-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is SXTC's financial strength grade?

China SXT Pharmaceuticals, Inc. (SXTC) earns a financial strength grade of A+, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is SXTC's Piotroski score?

China SXT Pharmaceuticals, Inc. (SXTC) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.